Title:
β-カテニン/TCF活性化転写の調節
Document Type and Number:
Japanese Patent JP2007503816
Kind Code:
A
Abstract:
The present invention provides compounds and methods for modulating transcription activated by beta-catenin/TCF, such as the selective inhibition of genes targeted by the Wnt/beta-catenin pathway.
Inventors:
Khan, Michael
Oh, Seung
Kim, Dae Hoon
Ha, John-Ryul
Hojati-Emami, Katayun
Oh, Seung
Kim, Dae Hoon
Ha, John-Ryul
Hojati-Emami, Katayun
Application Number:
JP2006524937A
Publication Date:
March 01, 2007
Filing Date:
August 27, 2004
Export Citation:
Assignee:
Chong We Pharma Corporation
International Classes:
C12N15/09; A61K31/00; A61K31/4985; A61K31/5025; A61K31/519; A61K31/53; A61K45/00; A61P1/00; A61P13/08; A61P15/00; A61P35/00; A61P43/00; C07D487/04; C07D519/00; C07K14/47; C12N5/06; C12N5/08; C12Q1/02; C12Q1/18; C12Q1/68; G01N33/15; G01N33/50
Foreign References:
| WO2003031448A1 | 2003-04-17 |
Attorney, Agent or Firm:
Ikeuchi, Sato & Partners